Laboratory Corporation of America Holdings is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care.
Industry sector: Medical
Sector classification: Medical laboratories
Deep Learning based analysis and prediction model for Laboratory Corporation of America Holdings (LH) stock is a 2nd Generation Non-linear Autoregressive (NAR) model based on the LSTM/GRU Recurrent Neural Network architecture.
Model is in the production pipeline since Oct. 22, 2015.
Market data for LH model training are being downloaded from the
Quandl premium datasets on a daily basis.
Risks related to the novel coronavirus disease 2019 (COVID-19) caused by the virus named “SARS-CoV-2” are
accounted for in this model in the form of the historical data coincided with outbreaks and other
global events in the past used to train ML prediction model for LH.
Model is being retrained on a regular basis.
| Float | 101M |
| P/E | 16.83 |
| Shares Outstanding | 102M |
| % Held by Insiders | 0.73% |
| % Held by Institutions | 92.64% |
| EPS (last reported FY) | $9.60 |
| EPS (last reported Q) | $2.78 |
| EPS, estimated (last reported Q) | $2.64 |
| Total revenues | $10 B |
| Net income | $1 B |